Exact FDA event identifier

Event 65702

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: June 13, 2013
Product types: Drug
Classifications: Class III
Statuses: Terminated
Recalling firm wording: Bayer HealthCare Pharmaceuticals Inc.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin

D-807-2013

Recall number: D-807-2013
Initiated: June 13, 2013
Classification: Class III
Status: Terminated
Recalling firm: Bayer HealthCare Pharmaceuticals Inc.
Quantity: 194.62 kg

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Out of specification

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.

Code information

Lot 87100040

Distribution pattern

NY, CA